Evidence map›Paper›PMID 30857592›Full record

ArticleeLife2019

Functional proteomic atlas of HIV infection in primary human CD4+ T cells.

Adi Naamati, James C Williamson, Edward Jd Greenwood, Sara Marelli, Paul J Lehner, Nicholas J Matheson

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 45 citations in OpenAlex.

  1. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Structural insights into PPP2R5A degradation by HIV-1 Vif.Nature structural & molecular biology · 2024
    Article
  8. Review
  9. Review
  10. Review
  11. Host Subcellular Organelles: Targets of Viral Manipulation.International journal of molecular sciences · 2024
    Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Adi NaamatiDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
James C WilliamsonDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Edward Jd GreenwoodDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-5224-0263
Sara MarelliDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Paul J LehnerCambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-9383-1054
Nicholas J MathesonDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-3318-1851
University of Cambridge · GB

Funding

Medical Research Council MR/P008801/1NHS Blood and Transplant WPA15-02Wellcome 210688/Z/18/ZWellcome Trust
6 · The paper itself

Abstract

Viruses manipulate host cells to enhance their replication, and the identification of cellular factors targeted by viruses has led to key insights into both viral pathogenesis and cell biology. In this study, we develop an HIV reporter virus (HIV-AFMACS) displaying a streptavidin-binding affinity tag at the surface of infected cells, allowing facile one-step selection with streptavidin-conjugated magnetic beads. We use this system to obtain pure populations of HIV-infected primary human CD4+ T cells for detailed proteomic analysis, and quantitate approximately 9000 proteins across multiple donors on a dynamic background of T cell activation. Amongst 650 HIV-dependent changes (q < 0.05), we describe novel Vif-dependent targets FMR1 and DPH7, and 192 proteins not identified and/or regulated in T cell lines, such as ARID5A and PTPN22. We therefore provide a high-coverage functional proteomic atlas of HIV infection, and a mechanistic account of host factors subverted by the virus in its natural target cell.

Indexed as

Gene Expression RegulationProteomeCD4-Positive T-LymphocytesCell SeparationCluster AnalysisDNA-Binding ProteinsFragile X Messenger Ribonucleoprotein 1Green Fluorescent ProteinsHIV-1HIV InfectionsHumansHydrogen-Ion ConcentrationLentivirusLymphocyte ActivationMagneticsMethyltransferasesARID5A protein, humanDNA-Binding ProteinsDPH7 protein, humanFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Green Fluorescent ProteinsMethyltransferasesProtein Tyrosine Phosphatase, Non-Receptor Type 22ProteomePTPN22 protein, humanStreptavidinvif Gene Products, Human Immunodeficiency Virusvif protein, Human immunodeficiency virus 1HIVhumanimmunologyinfectious diseaseinflammationmagnetic cell selectionmicrobiologyprimary human CD4+ T cellproteomicsvirus

Identifiers

PMID30857592
PMCPMC6414203
OpenAlexW2951393339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.